Health Care M&A Weekly Deals, The Week Ending March 2, 2018

We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report.

This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search.

Behavioral Health Care
AcquirerTargetPrice
Seven Hills Capital, LLCVersiCare GroupN/A
eHealth
AcquirerTargetPrice
Revint SolutionsNaveosN/A
Melissa DataIO Informatics, Inc.N/A
R1 RCM Inc.Intermedix Corporation$460 million
The SSI GroupInformatics Corporation of AmericaN/A
Home Health Care & Hospice
AcquirerTargetPrice
Addus HomeCare CorporationAmbercare Corporation$40 million
Hospitals
AcquirerTargetPrice
Maricopa Integrated Health SystemAbrazo Maryvale Campus$59 million
Laboratories, MRI and Dialysis
AcquirerTargetPrice
Eurofins ScientificNMDL-LCPLN/A
Long-Term Care
AcquirerTargetPrice
Heritage MinistriesRolling Fields Elder Care CommunityN/A
CommuniCare Health Services, Inc.Atrium CentersN/A
Strategic Student & Senior Housing Trust3 Assisted Living Communities$78.5 million
Local familyBancroft Convalescent HospitalN/A
Juniper Communities, LLCApplewood Place & Lakewood ReserveN/A
Medical Devices
AcquirerTargetPrice
Innovia Medical, LLCNetwork Medical Products LtdN/A
Abbott LaboratoriesExclusive license to SurVeil drug-coated balloon device$25 million
Pharmaceuticals
AcquirerTargetPrice
Randob Laboratories LtdBalmex brand$425 million
Mylan N.V.Collaboration and license to BOTOX biosimilar$25 million
Valeant Pharmaceuticals International Inc.Exclusive license to products containing KP-470N/A
Physician Medical Groups
AcquirerTargetPrice
Envision Healthcare CorporationChandler Radiology AssociatesN/A
Other
AcquirerTargetPrice
Kaplan Test PrepAssets of i-Human Patients, Inc.N/A
Centene CorporationMHM ServicesN/A
   

 

 

 

Leave a Reply

Your email address will not be published. Required fields are marked *